Similar articles for PMID: 24277710

Year	Number of Results
1974	1
1996	2
1999	1
2001	1
2002	1
2003	1
2004	1
2005	1
2006	3
2007	4
2008	1
2009	1
2010	3
2012	2
2013	4
2014	7
2015	6
2016	21
2017	19
2018	18
2019	16
2020	5
2021	3
2022	10
2023	2
2024	0

1

Take-home naloxone kits preventing overdose deaths.

Eggertson L. Eggertson L. CMAJ. 2014 Jan 7;186(1):17. doi: 10.1503/cmaj.109-4663. Epub 2013 Nov 25. CMAJ. 2014. PMID: 24277710 Free PMC article. No abstract available.

2

Case files of the Drexel University Medical Toxicology Fellowship: methadone-induced QTc prolongation.

Wong SC, Roberts JR. Wong SC, et al. J Med Toxicol. 2007 Dec;3(4):190-4. doi: 10.1007/BF03160939. J Med Toxicol. 2007. PMID: 18072176 Free PMC article. No abstract available.

3

Take-home naloxone in Australia and beyond.

Olsen A, Dwyer R, Lenton S. Olsen A, et al. Drug Alcohol Rev. 2018 May;37(4):437-439. doi: 10.1111/dar.12700. Drug Alcohol Rev. 2018. PMID: 29744978 No abstract available.

4

Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.

Irvine MA, Buxton JA, Otterstatter M, Balshaw R, Gustafson R, Tyndall M, Kendall P, Kerr T, Gilbert M, Coombs D. Irvine MA, et al. Lancet Public Health. 2018 May;3(5):e218-e225. doi: 10.1016/S2468-2667(18)30044-6. Epub 2018 Apr 18. Lancet Public Health. 2018. PMID: 29678561 Free article.

5

Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data.

Moustaqim-Barrette A, Papamihali K, Mamdani Z, Williams S, Buxton JA. Moustaqim-Barrette A, et al. PLoS One. 2020 Sep 11;15(9):e0238618. doi: 10.1371/journal.pone.0238618. eCollection 2020. PLoS One. 2020. PMID: 32915834 Free PMC article.

6

Emergency naloxone for heroin overdose: naloxone is not the only opioid antagonist.

Brewer C. Brewer C. BMJ. 2006 Oct 7;333(7571):754-5. doi: 10.1136/bmj.333.7571.754-b. BMJ. 2006. PMID: 17023477 Free PMC article. No abstract available.

7

Lessons learned from ramping up a Canadian Take Home Naloxone programme during a public health emergency: a mixed-methods study.

Young S, Williams S, Otterstatter M, Lee J, Buxton J. Young S, et al. BMJ Open. 2019 Oct 28;9(10):e030046. doi: 10.1136/bmjopen-2019-030046. BMJ Open. 2019. PMID: 31662368 Free PMC article.

8

Office-based treatment of opioid-dependent patients.

Ferner RE, Daniels AM. Ferner RE, et al. N Engl J Med. 2003 Jan 2;348(1):81-2; author reply 81-2. doi: 10.1056/NEJM200301023480118. N Engl J Med. 2003. PMID: 12510051 No abstract available.

9

Reversal of Pediatric Opioid Toxicity with Take-Home Naloxone: a Case Report.

Lebin JA, Chen BC, Valento MJ. Lebin JA, et al. J Med Toxicol. 2019 Apr;15(2):134-135. doi: 10.1007/s13181-018-0695-z. Epub 2019 Jan 10. J Med Toxicol. 2019. PMID: 30632074 Free PMC article.

10

Factors associated with take-home naloxone kit usage in British Columbia: an analysis of administrative data.

Lei V, Ferguson M, Geiger R, Williams S, Liu L, Buxton JA. Lei V, et al. Subst Abuse Treat Prev Policy. 2022 Mar 31;17(1):25. doi: 10.1186/s13011-022-00452-8. Subst Abuse Treat Prev Policy. 2022. PMID: 35361228 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

119 results

Results by year